$0 – $90

6th Annual Women in Life-Sciences - Believe and Achieve

Actions and Detail Panel

$0 – $90

Event Information

Share this event

Date and time

Location

Location

Online event

Refund policy

Refund policy

No Refunds

Event description
6th Annual Women in Life Science - Virtual Event

About this event

Come hear the career stories, challenges, and successes of our esteemed panelists.

They will share with us their personal journeys in the biopharmaceutical industry, the challenges women can expect to face, as well as general advice for women (and others) hoping to build their careers in the Industry.

Sponsorship available: WCC PDA Sponsorship Program offers a unique opportunity for companies that want to strengthen brand image, increase visibility, and gain access to leaders of the San Francisco Bay Life-Science Community


		6th Annual Women in Life-Sciences - Believe and Achieve image

Panelists


		6th Annual Women in Life-Sciences - Believe and Achieve image

Quita Beeler Highsmith, MBA-Vice-President and Chief Diversity Officer at Genentech

Quita Highsmith is Vice President and Chief Diversity Officer at Genentech, a member of the Roche Group. Quita has co-authored several publications regarding health disparities including in the Journal of Oncology Practice and Contemporary Clinical Trials. She frequently presents at national and international forums and has co-authored abstracts at peer-reviewed conferences, including the American Association of Cancer Research’s conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved.

She is responsible for leading Genentech’s Diversity and Inclusion strategy, including recruiting, retaining, and developing diverse talent, investing in initiatives to support science education, and addressing barriers in clinical trial participation via Advancing Inclusive Research™.

Prior to her role as Chief Diversity Officer, Quita held leadership roles in Government Affairs and the Commercial organizations at both Genentech and Sanofi-Aventis.


		6th Annual Women in Life-Sciences - Believe and Achieve image

Robbi Wyatt-Vice President of Development and Commercial Quality at Gilead Sciences, Inc

Robbi has 30+ years of Pharmaceutical industry experience, mostly supporting Manufacturing Operations, and is currently the Vice President of Development and Commercial Quality at Gilead Sciences, Inc.. She began her career in Sterilization Validation and as a Microbiologist, worked on various projects to include Disinfectant Efficacy studies/programs, Product/Spore D-Value determinations and implementation of Isolator technology in labs and manufacturing. Robbi then worked for almost 10 years leading Aseptic Manufacturing operations, including Filling, Lyophilization, and Packaging. During that time, she trained in Japan in Lean Manufacturing principles which is responsible for her keen interest in continuous process improvement and root cause analysis.

For the past 18 years, Robbi has held various roles of increasing responsibility in Quality, with experience in Parenterals, API, Biologics and Solid Dose Packaging/Labeling. Since joining Gilead in 2011, she has ensured a strong, foundational Quality Culture as well as contributed to the successful building and regulatory approval of a brand new aseptic processing facility. Throughout her career, she has led countless regulatory inspections and has developed an esteemed reputation with both Regulators and industry colleagues. Robbi has a passion for building and growing strong teams through collaboration, inclusion and development.

She has a Bachelor of Science degree in Microbiology from the University of Wyoming.


		6th Annual Women in Life-Sciences - Believe and Achieve image

Deborah Baly-Vice President and Global Quality Business Partner at Bayer Biologics

Deborah Baly is vice president and global quality business partner for the Bayer Biologics Business Unit with responsibility for quality oversight of both their commercial and clinical biologics portfolio. She is currently focused on the establishment of the Cell & Gene Therapy platform at Bayer. She obtained her Ph. D. from the University of California Davis and completed postdoctoral studies at the National Institutes of Health in Bethesda MD. Dr. Baly began her career in academics with faculty positions at Rutgers University and the University of Medicine and Dentistry – NJ where she continued her focus in diabetes research. In 1991, Dr Baly joined Genentech and during her tenure was on core teams responsible for development of Herceptin and Avastin therapeutics. Her most memorable experience was supporting the development of Herceptin from Phase I through commercialization in 1997.

Dr. Baly joined Bayer in 1999 to help establish a biotech business platform within their pharmaceutical division. She returned to Genentech in 2004, beginning a career in quality that would span 20+ years. As Director of Clinical Quality, she helped define phase appropriate quality requirements to support efficient and compliant product development and established the Quality Product Steward role, providing a single point of contact for quality to development teams. In 2008 she became Senior Director, Product Quality Management with responsibility for quality oversight of the biologics commercial product portfolio. During her tenure, she oversaw the establishment of technical analytical control system management group, streamlining of product complaint management and reengineering of the annual product review process for the commercial biologic products. Dr. Baly has worked at several other Companies in the Bay area, including Coherus BioSciences where she was VP Quality Control and supported the development of several biosimilar development candidates.


		6th Annual Women in Life-Sciences - Believe and Achieve image

Ruby Casareno, Ph.D., Senior Vice President, Technical Operations at Allakos Inc

Ruby Casareno, Ph.D., serves as Senior Vice President, Technical Operations at Allakos Inc, leading the biologics drug substance and drug product process and analytical development, CMC project management, quality control, and supply chain & packaging organizations. Her team also oversees the outsourced manufacturing sites.

She is responsible for growing and scaling the Technical Operations organization to commercialize the lead antibody and expand the development pipeline. Prior to joining Allakos in 2017, Ruby served as Director of Outsourced Manufacturing and Manufacturing Sciences & Technology at Portola (now Alexion) and supported the commercialization of Andexanet in the US and Europe. Prior to Portola, she was responsible for clinical development of 9 biologics as Director of Process Development & Manufacturing at Oncomed Pharmaceuticals (now Mereo BioPharma).

Ruby held various scientific and cross-functional leadership positions at Seattle Genetics, Maxygen, Johnson &Johnson (Scios), Xoma and Bio-Rad Laboratories. Ruby has a Ph.D. in Chemistry from the Ohio State University.


		6th Annual Women in Life-Sciences - Believe and Achieve image

Shannon Utter-Executive Director, GxP Compliance at BioMarin Pharmaceutical Inc

Shannon Utter is an Executive Director in the Biotechnology industry with experience and focus in pharmaceuticals/diagnostics fields within Quality Assurance, Quality Control, Contract Manufacturing Operations, Facilities, and Compliance.

She started her career in Genentech’s first molecular biology QC laboratory as a summer intern in 1990 and then went on to work for Monogram BioSciences, LabCorp, and today she is with BioMarin Pharmaceutical. Based out of San Rafael, CA, Shannon is responsible for leading the Compliance Strategy organization, which provides independent compliance expertise across the GxPs to drive solutions and inform risk-based decision-making in key operations and strategic forums. This integration with key business partners provides a framework for her team to work with all stakeholders to prepare for and manage successful health authority inspections. Shannon draws on her diverse background and insights to identify and constructively challenge constraints. She has pioneered ways to leverage people, process and technologies in ways that better position the companies she is a part of to operate, while fiercely ensuring the quality, compliance, and safety of life-changing therapies developed for unmet medical needs.


		6th Annual Women in Life-Sciences - Believe and Achieve image

Shelly Pizarro- Head of CMC Project Management at Boehringer Ingelheim

Dr Shelly Pizarro is currently the Head of CMC Project Management and Technical Regulatory Affairs at Boehringer Ingelheim in Fremont, CA ensuring the success of multiple projects for biopharma clients and the BI clinical pipeline. Her life learning journey started with a talent for schoolwork, relentless “why” questions and scientific curiosity. It then took various turns to land with a PhD in chemistry, a post-doc with Sandia National Labs to develop microchip protein systems and first entry into the biotech industry with Genentech in technical leadership roles in process development for Drug Substance, Drug Product, and Global MSAT as well as matrix leadership of CMC teams.

Sponsored by


		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

		6th Annual Women in Life-Sciences - Believe and Achieve image

FAQs

How can I contact the organizer with any questions?

You can contact the event organizer sending an email to rsvp@wccpda.org, please allows few days for the response, emails will not be monitored on the day of the event.

Is my registration fee or ticket transferable?

Ticket is not reimbursable, however you have time until 10 days before the event to transfer it to whoever would like to attend in your behalf

My company would like to become a WCC PDA Sponsor, do you have a sponsorship program?

Yes, our WCC PDA Sponsorship Program offers a unique opportunity for companies that want to strengthen brand image, increase visibility, and gain access to leaders of the San Francisco Bay Life-Science Community

What is the dressing code?

Business casual

Cancellation Policy:

Dinner seating is confirmed and reserved in advance. We regret that no refunds can be offered for non-attendance. If a registrant cannot attend, substitutions are welcome until 10 days before the event. The chapter reserves the right to cancel a dinner meeting if the minimum number of attendees is not met by Monday prior to the event. The chapter reserves the right to not answer emails or phone calls on the day of the event

Privacy Policy:

We manage your personal data responsibly and align with PDA privacy policy.

REGISTRATION AGREEMENT: by registering to this event I consent the WCC PDA to record and/or photograph me and using those recording and/or photographs in the future WCC PDA promotional and marketing material, and to send me promotional information via email.

Share with friends

Date and time

Location

Online event

Refund policy

No Refunds

Save This Event

Event Saved